Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford Sciences Innovation (OSI) recently announced the acquisition of its portfolio company, Base Genomics, by US-based early cancer diagnostic leaders, Exact Sciences, for $410m. The partnership will enable Base Genomics to significantly accelerate its clinical and commercial development here in Oxford, potentially unlocking a new era of preventative medicine and improved patient outcomes.

Base Genomics logo

Base Genomics joined the BioEscalator in March 2020 after meeting stringent gateway criteria set by the BioEscalator Management Board, who recognised the company’s high growth potential. In 6 months, they have grown from one lab space to two labs and an office with a third lab soon to be occupied. The BioEscalator has been able to support this rapid expansion by providing flexible space and serviced facilities.

Base Genomics was co-founded in 2018 by two Oxford academics Dr Yibin Liu and Dr Chunxiao Song from the Ludwig Institute and OSI’s Entrepreneur in Residence, Oliver Waterhouse, now CEO at Base. Their aim was to focus on developing a simple blood test to detect early-stage cancers.

The underlying DNA methylation detection technology, TAPS, capable long-read DNA sequencing, was developed at the Ludwig Institute for Cancer Research by Drs Liu and Song. Base Genomics’ leadership team is completed by Oxford alumna Dr Vincent Smith and Prof Anna Schuh, who is also Director of Molecular Diagnostics at the University’s Department of Oncology.

The full story can be viewed on the BioEscalator website

Similar stories

Review highlights risk factors associated with violence in schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections

First comprehensive analysis of global impact of antimicrobial resistance (AMR) estimates resistance itself caused 1.27 million deaths in 2019 - more deaths than HIV/AIDS or malaria - and that antimicrobial-resistant infections played a role in 4.95 million deaths.

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

Plaster cast or metal pins to treat a broken wrist? The results are in.

An Oxford study published in The BMJ has found the use of metal K-wires (commonly known as ‘pins’) to hold broken wrist bones in place while they heal are no better than a traditional moulded plaster cast.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.

New research sheds light on how ultrasound could be used to treat psychiatric disorders

A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.